Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

343
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
343
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
439
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Progression to active TB post-TB preventive treatment among household contacts in India: Axshya Plus project (2021-2024).

IJTLD open·2026
Same author

Performance validation of a closed loop fully automated AI model for lung nodule stratification in screening cases.

Respiratory investigation·2026
Same author

Reply to Authors: addressing concerns to ensure effective TB preventive therapy.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Burden and challenges in managing TB infection among people with occupational exposure to silica in India.

IJTLD open·2024
Same author

3HP preventive treatment among children and adolescents with HIV and child household contacts of TB patients.

IJTLD open·2024
Same author

Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV.

IJTLD open·2024

相关实验视频

Updated: Sep 9, 2025

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.3K

实施结核病预防治疗:印度大规模举措的教训

M Das1, A Kalra1, A S ThekkePurakkal1

  • 1FIND, New Delhi, India.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
|August 30, 2025
PubMed
概括

在家庭接触者中,3个月的利法丁- 异胺 (3HP) 治疗方案显示结核病预防治疗 (TPT) 的完成率很高. 与标准的6个月异化治疗方案相比,这种较短的TPT选择显示了可管理的不良事件和优异的坚持.

更多相关视频

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

相关实验视频

Last Updated: Sep 9, 2025

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.3K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.9K

科学领域:

  • 公共卫生
  • 传染性疾病
  • 临床试验

背景情况:

  • 结核病 (TB) 仍然是一个重大的全球健康挑战.
  • 世界卫生组织越来越多地建议使用较短时间的结核病预防治疗方案.
  • 印度结核消灭联合计划 (JEET) 正在评估新的结核治疗策略.

研究的目的:

  • 评估3个月的利法丁-异胺 (3HP) 治疗方案的早期实施结果.
  • 将3HP的特征,不良事件和治疗结果与标准6个月的每日异化物 (6H) 治疗方案进行比较.
  • 评估3HP在印度现实环境中的可行性和有效性.

主要方法:

  • 对肺结核患者的家庭接触者进行了一项描述性队列研究.
  • 在选定的地区, HHC 获得了 3HP 或 6H TPT.
  • 在两组中收集和比较了HHC特征,不良事件和TPT完成的数据.

主要成果:

  • 总共有635个HHC在3HP上启动,24350个HHC获得了6H.
  • 大约10%的3HP的HHC经历了AE,而6H则为4%.
  • 与6H (84%,P < 0. 001) 相比,3HP的完成率显著更高.

结论:

  • 3HP疗法实现了高TPT完成率,可控不良事件的发生率较低.
  • 这些发现支持在国家结核病计划中扩大3HP治疗方案.
  • 对于高结核病负担的国家来说,3HP是一个有前途且有效的较短的TPT选项.